Preliminary scientific tests reveal conolidine could inhibit particular ion channels, lessening neuronal excitability and limiting agony indicators. This mechanism is particularly suitable in neuropathic ache, where irregular signaling triggers persistent soreness. Also, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral